Simultaneous determination of morphine and monoamine transmitters in a single mouse brain.
A simple procedure for the simultaneous determination of morphine and monoamine transmitters was developed. The procedure consisted of (1) n-butanol extraction and (2) separation and quantitative determination by means of high-performance liquid chromatography combined with electrochemical detection. The maximum intracerebral concentration (210 +/- 35 ng/g wet tissue) of morphine was detected 30 min after intramuscular injection (10 mg/kg), which agreed with previous research. Noradrenaline was significantly decreased by morphine injection, while dopamine and 5-hydroxytryptamine were unchanged. However, 3-methoxytyramine, a metabolite of dopamine, was increased, suggesting that the drug increased the turnover rate of dopamine. The procedure used revealed a direct correlation between pharmacokinetics (e.g., distribution of morphine) and pharmacodynamics (e.g. changes of monoamine concentrations) of the drug in vivo.
D000818:Animals; D001679:Biogenic Amines / Q000032:analysis*; D001923:Brain Chemistry; D002851:Chromatography, High Pressure Liquid; D008297:Male; D051379:Mice; D009020:Morphine / Q000302:isolation & purification*; D018377:Neurotransmitter Agents / Q000032:analysis*; D013566:Sympathomimetics / Q000032:analysis
D001679:Biogenic Amines; D018377:Neurotransmitter Agents; D013566:Sympathomimetics; D009020:Morphine